Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biogalenic is a prominent Moroccan pharmaceutical company founded in 1995, specializing in the development, manufacturing, and marketing of generic pharmaceutical products. Headquartered in Casablanca, the company operates a state-of-the-art production facility that complies with international Good Manufacturing Practice (GMP) standards. Biogalenic's diverse portfolio encompasses a wide range of therapeutic areas, including cardiology, gastroenterology, infectiology, and neurology, providing high-quality and affordable healthcare solutions. In addition to its own product line, the company serves as a strategic contract manufacturing (CMO) partner for several multinational pharmaceutical firms looking to establish a presence in the North African market. Through its commitment to galenic innovation and rigorous quality control, Biogalenic has established itself as a key player in the regional pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biogalenic.